Unregulated peptides are ‘truly the wild west’ right now — and the FDA’s next decision could have severe consequences

The panel’s recommendations could shape the future of popular peptides, but some doctors say the review process itself ...

Millions could gain easier access to popular peptides after FDA panel vote

An FDA panel voted to recommend six peptides including BPC-157, TB-500, and KPV for compounding by licensed pharmacies ...

FDA panel supports broadening access to peptides popular on the gray market

Advisers to the Food and Drug Administration voted in favor of easing regulation of popular peptides. The recommendations could pave the way for specialized pharmacies to produce them in the U.S.

An FDA Committee Just Voted in Favor of Peptides—Despite the Agency's Opposition

The group met on July 24 to vote on whether compounding pharmacies could legally dispense certain peptides.
JD Supra

FDA on Peptides A New Landscape for Compounders

Against a backdrop of public sentiment and statements pushing rapid adoption of peptides, FDA's PCAC recommends allowing use of six peptides ...

FDA’s Review Of Peptides Signals A Growing Public Health Challenge—Separating Science From Hype

A FDA advisory committee will review evidence surrounding peptides. Experts are concerned there is a paucity of evidence to ...

FDA advisers support easing restrictions on six peptides. Here’s what those drugs are and what happens next

Peptides have become one of the hottest trends in wellness, with promises like faster muscle recovery and healthier aging.

What would it take to get peptides on the shelf?

An FDA advisory panel recently voted to green-light some popular peptides. The decision brought enormous attention to the ...